Renal tubular dysgenesis
Overview
Renal tubular dysgenesis is a severe fetal kidney disorder characterized by the absence or poor development of the proximal tubules, leading to persistent lack of urine production before birth
Symptoms
Anuria: Total lack of fetal urine production, leading to severe and persistent low amniotic fluid levels.
Oligohydramnios: Profoundly low amniotic fluid during pregnancy, usually starting around the 20th week or earlier.
Potter Sequence: A group of features caused by low amniotic fluid and compression in the womb, including flattened facial features, large and low-set ears, excess skin, and clubfeet.
Pulmonary Hypoplasia: Severely underdeveloped lungs that cause major breathing failure at birth.
Severe Arterial Hypotension: Dangerously low blood pressure occurring in the fetus or newborn.
Skull Ossification Defects: Abnormal or delayed bone formation in the skull, leaving large soft spaces (fontanelles) due to low blood flow and oxygenation
Causes
AGT: Mutations in the angiotensinogen gene disrupt the precursor protein needed to make angiotensin.
REN: Mutations in the renin gene prevent the production of renin, a vital enzyme that controls blood pressure and fluid balance.
ACE: Mutations in the angiotensin-converting enzyme gene stop the conversion of angiotensin I into active angiotensin II.
AGTR1: Mutations in the angiotensin II receptor type 1 gene prevent cells from responding to the signals that regulate blood vessel tone and kidney development.
ACE inhibitors and ARBs: Maternal exposure to certain blood pressure medications (like ACE inhibitors or angiotensin receptor blockers) during pregnancy can cause acquired dysgenesis in the fetus.
Fetal renal hypoperfusion: Conditions causing severe, prolonged low blood pressure or reduced blood flow to the fetal kidneys (such as severe fetal renal artery stenosis or twin-twin transfusion syndrome) can lead to the condition.
Diagnosis
Ultrasound Findings: Detects severe oligohydramnios (low amniotic fluid) with structurally normal-sized or slightly large, non-cystic kidneys that show increased echogenicity.
Physical Presentation: Neonates often display persistent anuria (inability to make urine), severe refractory hypotension (low blood pressure), and features of the Potter sequence (including lung hypoplasia and skull ossification defects/hypocalvaria).
Medical History: Evaluation includes checking for in utero exposure to renin-angiotensin system (RAS) blockers (like ACE inhibitors) or nonsteroidal anti-inflammatory drugs (NSAIDs).
Molecular Genetics: Whole-exome sequencing or targeted gene panels can identify pathogenic mutations in inherited autosomal recessive forms (such as variants in the ACE, REN, AGT, or AGTR1 genes).
Histological Examination: Postnatal kidney biopsy or autopsy provides definitive confirmation by revealing the characteristic absence or marked reduction and poor differentiation of the proximal tubules.
Fetal monitoring: Doctors watch for signs of severe oligohydramnios (low amniotic fluid).Maternal precautions: Pregnant mothers must avoid renin-angiotensin system blocking drugs (like ACE inhibitors), which can cause or worsen the condition.
Blood pressure support: Vasopressin, fludrocortisone, and fresh frozen plasma infusions help stabilize dangerously low blood pressure and maintain kidney perfusion.
Respiratory support: Mechanical ventilation or oxygen is often required for newborns with breathing difficulties or pulmonary hypoplasia.
Renal replacement therapy: Dialysis (such as peritoneal dialysis or continuous renal replacement therapy) may be used to remove waste products when kidneys fail.
Electrolyte and acid-base management: Medications like sodium bicarbonate and specific hormone supplements help correct severe imbalances in the blood.
Type of Doctor Department : A pediatric nephrologist or a nephrologist

Comments
Post a Comment